Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for BIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 1996. Start Trial.
Date Value
June 30, 2026 57.05%
March 31, 2026 -89.02%
December 31, 2025
September 30, 2025 -52.36%
June 30, 2025 48.77%
March 31, 2025 10.93%
December 31, 2024 -107.2%
September 30, 2024
June 30, 2024 -339.2%
March 31, 2024 62.85%
December 31, 2023 51.34%
September 30, 2023 16.81%
June 30, 2023 -170.6%
March 31, 2023 10.19%
December 31, 2022
September 30, 2022 -23.91%
June 30, 2022 -133.9%
March 31, 2022 -481.0%
December 31, 2021 -214.6%
September 30, 2021
June 30, 2021
March 31, 2021
December 31, 2020
September 30, 2020
June 30, 2020
Date Value
March 31, 2020
December 31, 2019 88.64%
September 30, 2019 -46.16%
June 30, 2019
March 31, 2019
December 31, 2018 -134.9%
September 30, 2018 49.41%
June 30, 2018 46.54%
March 31, 2018
December 31, 2017 13.32%
September 30, 2017 4.13%
June 30, 2017 1.00%
March 31, 2017 2.48%
December 31, 2016 -3.60%
September 30, 2016 3.62%
June 30, 2016 3.49%
March 31, 2016 2.61%
December 31, 2015 8.67%
September 30, 2015 3.70%
June 30, 2015 5.62%
March 31, 2015 3.77%
December 31, 2014 6.53%
September 30, 2014 2.17%
June 30, 2014 5.89%
March 31, 2014 1.31%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Thermo Fisher Scientific, Inc. 14.52%
Agilent Technologies, Inc. 18.47%
Danaher Corp. 13.89%
Illumina, Inc. 17.83%
Revvity, Inc. 7.33%